Skip to content

Clinical trials

Observational Arrhythmias, Cardiac trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arrhythmias, Cardiac Phase: Observational Clear all

488 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20023
20037
20046
20054
20068
20077
20089
20099
201014
201115
201211
201311
201412
201517
201620
201725
201829
201921
202032
202134
202238
202346
202436
202522
202627

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed227
Unknown status105
Recruiting81
Not yet recruiting30
Active, not recruiting17
Terminated16
Withdrawn7
Enrolling by invitation5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices18
National Heart, Lung, and Blood Institute (NHLBI)13
Medtronic Cardiac Rhythm and Heart Failure12
Assiut University8
Boston Scientific Corporation7
University Hospital of Ferrara7
Insel Gruppe AG, University Hospital Bern6
Stanford University6
Emory University5
Mayo Clinic5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arrhythmias, Cardiac488
Atrial Fibrillation124
Heart Failure80
Cardiovascular Diseases55
Heart Diseases53
Death, Sudden, Cardiac50
Tachycardia, Ventricular28
Cardiomyopathies27
Bradycardia26
Myocardial Infarction24

Trials

Showing 51 to 75 of 488. Each trial links to its page on Pharma Observatory.

388 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.